Skimmin, a coumarin, suppresses the streptozotocin-induced diabetic nephropathy in wistar rats

European Journal of Pharmacology

Volumn 692, Issue 1-3, 2012, Pages 78-83

  Zhang, Sen ^a   Yang, Jingzhi ^a   Li, Hongyan ^a   Li, Yan ^a   Liu, Yue ^a   Zhang, Dongming ^a   Zhang, Furong ^a   Zhou, Wanqi ^a   Chen, Xiaoguang ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Diabetic nephropathy; Skimmin; Streptozotocin; TGF 1

Indexed keywords

COUMARIN; GLUCOSE; LOSARTAN; SKIMMIN; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BIOCHEMISTRY; BLOOD; BLOOD SAMPLING; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GLOMERULOSCLEROSIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HISTOLOGY; KIDNEY PARENCHYMA; KIDNEY TUBULE DISORDER; MALE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUBULE VACUOLAR DEGENERATION; URINALYSIS; WESTERN BLOTTING;

ANIMALS; COUMARINS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GENE EXPRESSION REGULATION; HYPOGLYCEMIC AGENTS; KIDNEY; MALE; RATS; RATS, WISTAR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84865857565     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.05.017     Document Type: Article

References (20)

1. B.M. Brenner, M.E. Cooper, D. de Zeeuw, W.F. Keane, W.E. Mitch, H.H. Parving, G. Remuzzi, S.M. Snapinn, Z. Zhang, and S. Shahinfar Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N. Engl. J. Med. 345 2001 861 869
2. K. Doi, T. Kojima, M. Makino, Y. Kimura, and Y. Fujimoto Studies on the constituents of the leaves of Morus alba L Chem. Pharm. Bull. 49 2001 151 153
3. P. Franzen, P. ten Dijke, H. Ichijo, H. Yamashita, P. Schulz, C.H. Heldin, and K. Miyazono Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor Cell 75 1993 681 692
4. E. Gagliardini, and A. Benigni Role of anti-TGF-beta antibodies in the treatment of renal injury Cytokine Growth Factor Rev. 17 2006 89 96
5. E. Gagliardini, and A. Benigni Therapeutic potential of TGF-beta inhibition in chronic renal failure Expert Opin. Biol. Ther. 7 2007 293 304
6. P.F. Iqbal, A.R. Bhat, and A. Azam Antiamoebic coumarins from the root bark of Adina cordifolia and their new thiosemicarbazone derivatives Eur. J. Med. Chem. 44 2009 2252 2259
7. K. Kai, B. Shimizu, M. Mizutani, K. Watanabe, and K. Sakata Accumulation of coumarins in Arabidopsis thaliana Phytochemistry 67 2006 379 386
8. H. Li, Y. Zhang, H. Wang, X. Zheng, and X. Chen Nicousamide blocks the effects of advanced glycation end products on renal cells Eur. J. Pharmacol. 674 2012 455 459
9. H. Li, X. Zheng, H. Wang, Y. Zhang, H. Xin, and X. Chen XLF-III-43, a novel coumarin-aspirin compound, prevents diabetic nephropathy in rats via inhibiting advanced glycation end products Eur. J. Pharmacol. 627 2010 340 347
10. H.Y. Lin, X.F. Wang, E. Ng-Eaton, R.A. Weinberg, and H.F. Lodish Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase Cell 68 1992 775 785
11. S.M. Mauer, M.W. Steffes, E.N. Ellis, D.E. Sutherland, D.M. Brown, and F.C. Goetz Structural-functional relationships in diabetic nephropathy J. Clin. Invest. 74 1984 1143 1155
12. E.P. Mensah-Brown, E.N. Obineche, S. Galadari, E. Chandranath, A. Shahin, I. Ahmed, S.M. Patel, and A. Adem Streptozotocin-induced diabetic nephropathy in rats: the role of inflammatory cytokines Cytokine 31 2005 180 190
13. H.H. Parving, H. Lehnert, J. Brochner-Mortensen, R. Gomis, S. Andersen, and P. Arner The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes N. Engl. J. Med. 345 2001 870 878
14. W.B. Reeves, and T.E. Andreoli Transforming growth factor beta contributes to progressive diabetic nephropathy Proc. Natl. Acad. Sci. U. S. A. 97 2000 7667 7669
15. E. Ritz, and S.R. Orth Nephropathy in patients with type 2 diabetes mellitus N. Engl. J. Med. 341 1999 1127 1133
16. L.M. Ruilope Renoprotection and renin-angiotensin system blockade in diabetes mellitus Am. J. Hypertens. 10 1997 325S 331S
17. M. Sasaki, S. Uehara, H. Ohta, K. Taguchi, M. Kemi, M. Nishikibe, and H. Matsumoto Losartan ameliorates progression of glomerular structural changes in diabetic KKAy mice Life Sci. 75 2004 869 880
18. E.J. Sohn, C.S. Kim, Y.S. Kim, D.H. Jung, D.S. Jang, Y.M. Lee, and J.S. Kim Effects of magnolol (5,5′-diallyl-2,2′-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats Life Sci. 80 2007 468 475
19. H.-j. Zhang, J. Jin, W.-q. Zhou, Y. Zhang, Y. Li, J.-y. Liu, S. Zhang, and X Chen -g Nicousamide, a potent inhibitor of phosphorylation by TGF-β receptor II. Acta Pharmaceutica Sinica B 1 2011 160 165
20. F.N. Ziyadeh, B.B. Hoffman, D.C. Han, M.C. Iglesias-De La Cruz, S.W. Hong, M. Isono, S. Chen, T.A. McGowan, and K Sharma Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice Proc. Natl. Acad. Sci. U. S. A. 97 2000 8015 8020